Pressure-related nerve injury (PRNI) in intensive care unit (ICU) settings remains a significant yet often underrecognized complication affecting critically ill patients. This review synthesizes recent evidence on the epidemiology, pathophysiology, risk factors, clinical features, diagnosis, and management of ICU-acquired PRNI. Emphasis is placed on elucidating mechanisms of nerve injury, identifying high-risk populations, and integrating guideline-based strategies for prevention and early intervention. The review further explores emerging therapies and underscores the necessity of multidisciplinary approaches for optimal outcomes.
ICU patients are uniquely susceptible to a wide array of complications due to prolonged immobilization, critical illness, and complex interventions. Among these, pressure-related nerve injury—encompassing compressive mononeuropathies and plexopathies—warrants heightened clinical attention. These injuries may result in persistent functional impairment, increased morbidity, and delayed rehabilitation. Despite the availability of preventive measures, the incidence of PRNI remains substantial, necessitating a comprehensive understanding of its risk assessment and management.
The reported incidence of PRNI in ICU populations varies widely, with studies estimating rates between 2% and 15%, depending on patient cohorts, duration of ICU stay, and screening protocols. Peripheral nerve injuries are more prevalent in patients subjected to prolonged mechanical ventilation, neuromuscular blockade, or proning. Notably, the COVID-19 pandemic saw a surge in cases associated with extended periods of prone positioning, further highlighting the clinical burden. PRNI contributes to increased length of hospital stay, higher rehabilitation needs, and, in some cases, permanent disability, underscoring its significance as a healthcare concern.
PRNI primarily arises from sustained external compression, leading to ischemia of peripheral nerves. This may culminate in a spectrum of injuries ranging from neurapraxia to axonotmesis and, in severe cases, neurotmesis. The pathophysiological sequence involves compromised microvascular perfusion, disruption of axonal transport, endoneurial edema, demyelination, and eventual Wallerian degeneration if pressure is not relieved. Anatomical vulnerability—such as superficial nerves (e.g., ulnar, peroneal, and radial)—predisposes certain sites to injury, especially when compounded by critical illness neuropathy or myopathy.
Multiple patient- and treatment-related factors elevate the risk of PRNI in the ICU. These include advanced age, low body mass index, diabetes mellitus, pre-existing neuropathies, and hypoalbuminemia. Procedural factors, such as prolonged immobility, use of vasopressors, deep sedation, neuromuscular blockade, and specific positioning (notably prone or lateral decubitus), further amplify risk. Devices such as tight restraints, blood pressure cuffs, and poorly padded splints may contribute to localized nerve compression. Recognition of these risk factors is integral to targeted preventive strategies.
Clinical manifestations of PRNI depend on the affected nerve and the severity of injury. Patients may present with sensory deficits (numbness, paresthesia), motor weakness, or both, often corresponding to the anatomical distribution of the compromised nerve. Ulnar nerve palsy, peroneal nerve palsy, and brachial plexopathy are among the most frequently observed patterns. In sedated or non-communicative patients, signs such as limb posturing, muscle atrophy, or loss of deep tendon reflexes may be the earliest indicators. Early recognition is challenging but crucial to minimize long-term sequelae.
The diagnostic approach to ICU-acquired PRNI relies on high clinical suspicion, systematic neurological examination, and, when feasible, electrophysiological studies. Nerve conduction studies and electromyography can help localize lesions, differentiate between demyelinating and axonal injuries, and assess severity. Imaging modalities such as ultrasonography and MRI may be valuable in complex cases to evaluate nerve continuity and exclude compressive masses or hematomas. Timely diagnosis is essential to guide intervention and prevent further damage.
Management of PRNI in the ICU focuses on both prevention and early intervention. Preventive strategies include regular repositioning, meticulous padding of pressure-prone areas, optimizing patient positioning (especially during proning), and minimizing the use of constrictive devices. In cases of established nerve injury, prompt pressure relief, physiotherapy, and occupational therapy are central to recovery. Pharmacologic options for neuropathic pain may be considered. Severe or refractory cases may require surgical consultation for decompression or neurolysis.
Recent innovations in ICU care have introduced advanced pressure-mapping technologies and smart mattresses designed to reduce focal pressure points. Use of wearable sensors for real-time monitoring of limb position and pressure is being explored to aid early detection. Enhanced staff education, multidisciplinary mobility teams, and standardized protocols for high-risk procedures—such as proning—have demonstrated efficacy in reducing PRNI incidence. Experimental therapies targeting nerve regeneration and neuroprotection are under investigation but remain largely preclinical.
Contemporary guidelines emphasize a proactive, multidisciplinary approach to PRNI prevention in the ICU. Key recommendations include comprehensive risk assessment upon admission, individualized positioning protocols, daily neurological evaluations, and ongoing staff training. The adoption of checklists for proning and sedation holidays to facilitate neurological examination are strongly endorsed. Early rehabilitation and continuity of care post-ICU discharge are critical components for optimizing long-term outcomes.
ICU pressure-related nerve injury constitutes a preventable yet clinically impactful complication among critically ill patients. Robust risk assessment, vigilant monitoring, and implementation of guideline-directed preventive measures are paramount to reducing incidence and severity. Integration of technological advances and multidisciplinary collaboration will continue to shape the landscape of PRNI management. Early recognition and intervention remain cornerstones for preserving neurological function and improving patient-centered outcomes in the ICU setting.
1.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
New therapeutic strategies raised to prevent and resist metastasis in lymph nodes of breast cancer
4.
An understudied type of breast cancer poses a lurking threat
5.
More men with prostate cancer are avoiding unnecessary surgery
1.
Evidence-Based Approaches in Hematology for Modern Medicine
2.
The Importance of Having a Quick and Effective Heparin Antidote
3.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
4.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
5.
Targeted Therapies for Breast Cancer: What’s New?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
4.
Importance of Cancer Screening and Early Detection
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation